Healthcare Watch: Allscripts, Eclipsys Holders OK Merger

August 16, 2010 (FinancialWire) (Go to http://www.financialwire.net/?s=ftrdnwswnd for all of today’s featured news.) — Allscripts-Misys Healthcare Solutions, Inc. (NASDAQ: MDRX), a provider of clinical software, information and connectivity solutions for physicians, and Eclipsys Corp. (NASDAQ: ECLP), an enterprise provider of solutions and services for hospitals and clinicians, said that stockholders of each company approved the merger of Allscripts and Eclipsys.

At the special meeting of Allscripts stockholders, held on August 13, 99% of the Allscripts shares voted were in favor of the issuance of Allscripts shares to stockholders of Eclipsys in the merger.

At the special meeting of Eclipsys stockholders, also held on the 13th, 99% of the Eclipsys shares voted approved the merger (representing 83% of the shares outstanding).

Under the terms of a merger agreement reported on June 9, Eclipsys stockholders will receive 1.2 shares of Allscripts for each share of Eclipsys.

Allscripts and Eclipsys said they expect the transaction to be completed promptly after all other conditions to the merger are satisfied, including the completion of the sale of no less than 25 million shares of Allscripts common stock currently held by Misys plc in an underwritten public offering and the completion of Allscripts repurchase from Misys (or one or more of its subsidiaries) of 24.4 million shares of Allscripts common stock.

Illinois-based Allscripts’ solutions include electronic health records, electronic prescribing, revenue cycle management, practice management, document management, care management, emergency department information systems and homecare automation.

Georgia-based Eclipsys is a provider of integrated clinical, revenue cycle and performance management software, clinical content and professional services used by healthcare organizations.

Real-time, streaming research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://investrend.stocksmart.com/ss/html/hpcompany.html). Current valuation analysis research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://www.valuengine.com/rep/searchsrep?pid=42&srchfor=).

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public other companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (at http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation from subject entities, companies, equities, or representatives thereof, for its news, opinions or distributions. Further disclosure is posted at the FinancialWire(tm) website (at http://www.financialwire.net/disclosures.php and http://www.financialwire.net/2010/04/23/safe-harbor/). Additional resources for investors are also accessible via the FinancialWire(tm) website (at http://www.financialwire.net/2010/04/23/investor-resources/). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Copyright © MMX, FinancialWire(tm); All rights reserved.

[hlmsmlh] [hlthcrdp] [mrgrsacqstns] [tchnlgy] [infrntntchnlgy] [prfssnlsrvctsrc] [ftrdnwswnd]